Document Detail


Absorption enhancement study of astragaloside IV based on its transport mechanism in caco-2 cells.
MedLine Citation:
PMID:  16715776     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The purpose of this study was to investigate the transport characteristics and mechanisms for discovering the possible causes of the low bioavailability of astragaloside IV and to develop an absorption enhancement strategy. Caco-2 cells used as the in vitro model. Results showed a low permeability coefficient (3.7 x 10(-8)cm/s for transport from the AP to BL direction), which remained unchanged throughout the concentration range studied, indicating that the transport of astragaloside IV was predominantly via a passive route. The AP to BL transport of astragaloside IV was found to be highly sensitive to the extracellular Ca2+ concentration, which suggested that its transport may be via a paracellular route. Both chitosan and sodium deoxycholate can increase the permeation efficiency of astragaloside IV. This study indicated that astragaloside IV having a low fraction dose absorbed in humans mainly due to its poor intestinal permeability, high molecular weight, low lipophilicity as well as its paracelluar transport may directly result in the low permeability through its passive transport. Meanwhile, chitosan and sodium deoxycholate can be used as absorption enhancers based on its transport mechanism.
Authors:
C R Huang; G J Wang; X L Wu; H Li; H T Xie; H Lv; J G Sun
Related Documents :
17379846 - Roles of nitric oxide and angiotensin ii in the impaired baroreflex gain of pregnancy.
21565996 - Contributions of an animal scientist to reproductive biology.
2853216 - Influence of medium polarity on the photosensitizing properties of hematoporphyrin and ...
25171856 - Discontinuation of antipsychotic medication in pregnancy: a cohort study.
11507706 - Maternally separated rats show deficits in maternal care in adulthood.
11820256 - Trends in species causing fungaemia in a tertiary care medical centre over 12 years.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of drug metabolism and pharmacokinetics     Volume:  31     ISSN:  0378-7966     ISO Abbreviation:  Eur J Drug Metab Pharmacokinet     Publication Date:    2006 Jan-Mar
Date Detail:
Created Date:  2006-05-23     Completed Date:  2006-07-25     Revised Date:  2011-02-02    
Medline Journal Info:
Nlm Unique ID:  7608491     Medline TA:  Eur J Drug Metab Pharmacokinet     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  5-10     Citation Subset:  IM    
Affiliation:
Drug Metabolism and Pharmacokinetic Research Center, China Pharmaceutical University, Nanjing, People's Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Algorithms
Biological Availability
Biological Transport / drug effects
Caco-2 Cells
Chelating Agents / pharmacology
Chitosan / pharmacology
Chromatography, Liquid
Data Interpretation, Statistical
Deoxycholic Acid / pharmacology
Edetic Acid / pharmacology
Humans
Intestinal Absorption / drug effects*
Saponins / metabolism,  pharmacology*
Spectrometry, Mass, Electrospray Ionization
Stimulation, Chemical
Triterpenes / metabolism,  pharmacology*
Chemical
Reg. No./Substance:
0/Chelating Agents; 0/Saponins; 0/Triterpenes; 60-00-4/Edetic Acid; 83-44-3/Deoxycholic Acid; 83207-58-3/astragaloside A; 9012-76-4/Chitosan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  An improved high-performance liquid chromatographic determination of chloroquine and its major metab...
Next Document:  Substrate specificity of guinea pig liver aldehyde oxidase and bovine milk xanthine oxidase for meth...